Gerd Bauerschmitz

2.1k total citations
55 papers, 1.6k citations indexed

About

Gerd Bauerschmitz is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Gerd Bauerschmitz has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 34 papers in Molecular Biology and 28 papers in Oncology. Recurrent topics in Gerd Bauerschmitz's work include Virus-based gene therapy research (32 papers), CAR-T cell therapy research (23 papers) and Viral Infectious Diseases and Gene Expression in Insects (13 papers). Gerd Bauerschmitz is often cited by papers focused on Virus-based gene therapy research (32 papers), CAR-T cell therapy research (23 papers) and Viral Infectious Diseases and Gene Expression in Insects (13 papers). Gerd Bauerschmitz collaborates with scholars based in Germany, United States and Finland. Gerd Bauerschmitz's co-authors include Akseli Hemminki, Anna Kanerva, David T. Curiel, Minghui Wang, Ronald D. Alvarez, Renée A. Desmond, John Lam, Shannon Barker, Dirk M. Nettelbeck and Gene P. Siegal and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Gerd Bauerschmitz

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerd Bauerschmitz Germany 23 1.3k 1.0k 930 287 153 55 1.6k
Lotta Kangasniemi Finland 16 840 0.7× 542 0.5× 685 0.7× 243 0.8× 120 0.8× 24 1.0k
Sari Pesonen Finland 20 659 0.5× 537 0.5× 700 0.8× 219 0.8× 107 0.7× 33 1.1k
Sari Pesonen Finland 16 734 0.6× 448 0.4× 629 0.7× 206 0.7× 108 0.7× 24 947
Siri Tähtinen Finland 20 837 0.7× 670 0.6× 1.0k 1.1× 226 0.8× 204 1.3× 32 1.6k
Zeng B. Zhu United States 24 776 0.6× 823 0.8× 552 0.6× 157 0.5× 52 0.3× 45 1.4k
Conrado Soria United States 8 519 0.4× 558 0.5× 476 0.5× 126 0.4× 66 0.4× 8 913
Joan Kyula United Kingdom 21 443 0.3× 460 0.4× 576 0.6× 142 0.5× 130 0.8× 33 1.0k
Heung Chong United Kingdom 18 758 0.6× 874 0.8× 537 0.6× 171 0.6× 66 0.4× 36 1.5k
Paul Shabram United States 12 578 0.5× 740 0.7× 322 0.3× 100 0.3× 155 1.0× 21 1.0k
Lynette P. Steele United Kingdom 15 613 0.5× 362 0.4× 506 0.5× 166 0.6× 229 1.5× 19 1.0k

Countries citing papers authored by Gerd Bauerschmitz

Since Specialization
Citations

This map shows the geographic impact of Gerd Bauerschmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Bauerschmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Bauerschmitz more than expected).

Fields of papers citing papers by Gerd Bauerschmitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Bauerschmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Bauerschmitz. The network helps show where Gerd Bauerschmitz may publish in the future.

Co-authorship network of co-authors of Gerd Bauerschmitz

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Bauerschmitz. A scholar is included among the top collaborators of Gerd Bauerschmitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Bauerschmitz. Gerd Bauerschmitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauerschmitz, Gerd, et al.. (2023). Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells. Cancer Genomics & Proteomics. 20(3). 281–297. 14 indexed citations
2.
Bauerschmitz, Gerd, et al.. (2023). Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells. International Journal of Molecular Sciences. 24(18). 13705–13705. 3 indexed citations
3.
Bauerschmitz, Gerd, et al.. (2023). Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61. Cancer Genomics & Proteomics. 20(6). 531–538. 7 indexed citations
4.
Wegwitz, Florian, et al.. (2020). Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells. Cells. 9(12). 2616–2616. 7 indexed citations
5.
Rein, Daniel, Anne Kathrin Volkmer, Gerd Bauerschmitz, et al.. (2011). Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer. Journal of Cancer Research and Clinical Oncology. 138(4). 603–610. 9 indexed citations
6.
Rein, Daniel, Anne Kathrin Volkmer, Ines Beyer, et al.. (2011). Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus. Gynecologic Oncology. 123(1). 138–146. 12 indexed citations
7.
Hemminki, Otto, Gerd Bauerschmitz, Silvio Hemmi, et al.. (2010). Oncolytic adenovirus based on serotype 3. Cancer Gene Therapy. 18(4). 288–296. 47 indexed citations
8.
Diaconu, Iulia, Vincenzo Cerullo, Sophie Escutenaire, et al.. (2010). Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir. The Journal of Gene Medicine. 12(5). 435–445. 32 indexed citations
9.
Pesonen, Sari, Petri Nokisalmi, Ari Ristimäki, et al.. (2008). Treatment of cancer patients with capsid modified double controlled oncolytic adenovirus Ad5/3-Cox2L-D24. Cancer Research. 68. 2818–2818. 1 indexed citations
10.
Kanerva, Anna, Sergio Lavilla-Alonso, Mari Raki, et al.. (2008). Systemic Therapy for Cervical Cancer with Potentially Regulatable Oncolytic Adenoviruses. PLoS ONE. 3(8). e2917–e2917. 15 indexed citations
11.
Eriksson, Minna, Kilian Guse, Gerd Bauerschmitz, et al.. (2007). Oncolytic Adenoviruses Kill Breast Cancer Initiating CD44+CD24–/Low Cells. Molecular Therapy. 15(12). 2088–2093. 83 indexed citations
12.
Guse, Kilian, João D. Dias, Gerd Bauerschmitz, et al.. (2007). Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo. Gene Therapy. 14(11). 902–911. 27 indexed citations
13.
Rein, Daniel, Martina Breidenbach, Tyler O. Kirby, et al.. (2005). A Fiber-Modified, Secretory Leukoprotease Inhibitor Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer. Clinical Cancer Research. 11(3). 1327–1335. 36 indexed citations
14.
Glasgow, Joel N., Gerd Bauerschmitz, D T Curiel, & Akseli Hemminki. (2004). Transductional and Transcriptional Targeting of Adenovirus for Clinical Applications. Current Gene Therapy. 4(1). 1–14. 65 indexed citations
15.
Dall, Peter, et al.. (2004). In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells. Cancer Immunology Immunotherapy. 54(1). 51–60. 21 indexed citations
16.
Volk, Andrea L., Ángel A. Rivera, Anna Kanerva, et al.. (2003). Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism. Cancer Biology & Therapy. 2(5). 511–515. 59 indexed citations
17.
Hemminki, Akseli, Anna Kanerva, Eric J. Kremer, et al.. (2003). A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model. Molecular Therapy. 7(2). 163–173. 83 indexed citations
18.
Kanerva, Anna, Kurt R. Zinn, Tandra R. Chaudhuri, et al.. (2003). Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Molecular Therapy. 8(3). 449–458. 143 indexed citations
19.
Bauerschmitz, Gerd, Dirk M. Nettelbeck, Anna Kanerva, et al.. (2002). The flt-1 promoter for transcriptional targeting of teratocarcinoma.. PubMed. 62(5). 1271–4. 22 indexed citations
20.
Bauerschmitz, Gerd, et al.. (2001). Das Risiko der Uterusruptur nach vorausgegangenem Kaiserschnitt - eine Analyse von 1 086 Geburten. Zentralblatt für Gynäkologie. 123(3). 148–152. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lotta Kangasniemi Breakdown of academic impact, for papers by Sari Pesonen Breakdown of academic impact, for papers by Sari Pesonen Breakdown of academic impact, for papers by Siri Tähtinen Breakdown of academic impact, for papers by Zeng B. Zhu Breakdown of academic impact, for papers by Conrado Soria Breakdown of academic impact, for papers by Joan Kyula Breakdown of academic impact, for papers by Heung Chong Breakdown of academic impact, for papers by Paul Shabram Breakdown of academic impact, for papers by Lynette P. Steele
Rankless by CCL
2026